What is the current size of digital diabetes management market?

The global digital diabetes management market size was reached at USD 26.85 billion in 2023 and it is anticipated to rake around USD 171.63 billion by 2034. Read More

What will be the CAGR of global digital diabetes management market?

The global digital diabetes management market is poised to hit growth at a CAGR of 18.3% from 2024 to 2034. Read More

Who are the major players operating in the digital diabetes management market?

The major players operating in the digital diabetes management market are Bayer AG, Medtronic, Roche Diagnostics, Dexcom Inc. LifeScan Inc., AgaMatrix, One Drop, Abbott Laboratories, Ascensia Diabetes Care, ARKRAY Inc, ACON Laboratories, and Insulet Corporation. Read More

Which are the driving factors of the digital diabetes management market?

The major industry leaders operating in the digital diabetes management are focusing on providing innovative products and introducing advanced technologies in this market. Read More

Which region will lead the global digital diabetes management market?

North America dominated the digital diabetes management market in 2023 and will remains its dominance over the forecast period. Read More

Digital Diabetes Management Market Size, Share, and Trends 2024 to 2034

Digital Diabetes Management Market (By Product: Devices, Application, Data Management Software & Platforms, Services; By Device Type: Handheld Devices, Wearable Devices; By Patient Type: Type 1, Type 2; By App: Digital Diabetes Management Apps, Weight & Diet Management Apps; By End-Use: Hospitals, Home Settings, Diagnostic Centers & Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024 – 2034

Last Updated : August 2024
Report Code : 1783
Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Digital Diabetes Management Market

5.1. COVID-19 Landscape: Digital Diabetes Management Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Digital Diabetes Management Market, By Product

8.1. Digital Diabetes Management Market, by Product, 2024-2034

8.1.1. Devices

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Application

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Data Management Software & Platforms

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Services

8.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Digital Diabetes Management Market, By Device Type

9.1. Digital Diabetes Management Market, by Device Type, 2024-2034

9.1.1. Handheld Devices

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Wearable Devices

9.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Digital Diabetes Management Market, By Patient Type

10.1. Digital Diabetes Management Market, by Patient Type, 2024-2034

10.1.1. Type 1

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Type 2

10.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Digital Diabetes Management Market, By App

11.1. Digital Diabetes Management Market, by App, 2024-2034

11.1.1. Digital Diabetes Management Apps

11.1.1.1. Market Revenue and Forecast (2021-2034)

11.1.2. Weight & Diet Management Apps

11.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global Digital Diabetes Management Market, By End-Use

12.1. Digital Diabetes Management Market, by End-Use, 2024-2034

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast (2021-2034)

12.1.2. Home Settings

12.1.2.1. Market Revenue and Forecast (2021-2034)

12.1.3. Diagnostic Centers& Clinics

12.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 13. Global Digital Diabetes Management Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product (2021-2034)

13.1.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.1.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.1.4. Market Revenue and Forecast, by App (2021-2034)

13.1.5. Market Revenue and Forecast, by End-Use (2021-2034)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product (2021-2034)

13.1.6.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.1.6.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.1.6.4. Market Revenue and Forecast, by App (2021-2034)

13.1.7. Market Revenue and Forecast, by End-Use (2021-2034)

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Product (2021-2034)

13.1.8.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.1.8.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.1.8.4. Market Revenue and Forecast, by App (2021-2034)

13.1.8.5. Market Revenue and Forecast, by End-Use (2021-2034)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product (2021-2034)

13.2.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.2.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.2.4. Market Revenue and Forecast, by App (2021-2034)

13.2.5. Market Revenue and Forecast, by End-Use (2021-2034)

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product (2021-2034)

13.2.6.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.2.6.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.2.7. Market Revenue and Forecast, by App (2021-2034)

13.2.8. Market Revenue and Forecast, by End-Use (2021-2034)

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product (2021-2034)

13.2.9.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.2.9.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.2.10. Market Revenue and Forecast, by App (2021-2034)

13.2.11. Market Revenue and Forecast, by End-Use (2021-2034)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product (2021-2034)

13.2.12.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.2.12.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.2.12.4. Market Revenue and Forecast, by App (2021-2034)

13.2.13. Market Revenue and Forecast, by End-Use (2021-2034)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product (2021-2034)

13.2.14.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.2.14.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.2.14.4. Market Revenue and Forecast, by App (2021-2034)

13.2.15. Market Revenue and Forecast, by End-Use (2021-2034)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product (2021-2034)

13.3.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.3.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.3.4. Market Revenue and Forecast, by App (2021-2034)

13.3.5. Market Revenue and Forecast, by End-Use (2021-2034)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product (2021-2034)

13.3.6.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.3.6.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.3.6.4. Market Revenue and Forecast, by App (2021-2034)

13.3.7. Market Revenue and Forecast, by End-Use (2021-2034)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product (2021-2034)

13.3.8.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.3.8.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.3.8.4. Market Revenue and Forecast, by App (2021-2034)

13.3.9. Market Revenue and Forecast, by End-Use (2021-2034)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product (2021-2034)

13.3.10.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.3.10.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.3.10.4. Market Revenue and Forecast, by App (2021-2034)

13.3.10.5. Market Revenue and Forecast, by End-Use (2021-2034)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product (2021-2034)

13.3.11.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.3.11.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.3.11.4. Market Revenue and Forecast, by App (2021-2034)

13.3.11.5. Market Revenue and Forecast, by End-Use (2021-2034)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product (2021-2034)

13.4.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.4.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.4.4. Market Revenue and Forecast, by App (2021-2034)

13.4.5. Market Revenue and Forecast, by End-Use (2021-2034)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product (2021-2034)

13.4.6.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.4.6.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.4.6.4. Market Revenue and Forecast, by App (2021-2034)

13.4.7. Market Revenue and Forecast, by End-Use (2021-2034)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product (2021-2034)

13.4.8.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.4.8.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.4.8.4. Market Revenue and Forecast, by App (2021-2034)

13.4.9. Market Revenue and Forecast, by End-Use (2021-2034)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product (2021-2034)

13.4.10.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.4.10.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.4.10.4. Market Revenue and Forecast, by App (2021-2034)

13.4.10.5. Market Revenue and Forecast, by End-Use (2021-2034)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product (2021-2034)

13.4.11.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.4.11.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.4.11.4. Market Revenue and Forecast, by App (2021-2034)

13.4.11.5. Market Revenue and Forecast, by End-Use (2021-2034)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product (2021-2034)

13.5.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.5.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.5.4. Market Revenue and Forecast, by App (2021-2034)

13.5.5. Market Revenue and Forecast, by End-Use (2021-2034)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product (2021-2034)

13.5.6.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.5.6.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.5.6.4. Market Revenue and Forecast, by App (2021-2034)

13.5.7. Market Revenue and Forecast, by End-Use (2021-2034)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product (2021-2034)

13.5.8.2. Market Revenue and Forecast, by Device Type (2021-2034)

13.5.8.3. Market Revenue and Forecast, by Patient Type (2021-2034)

13.5.8.4. Market Revenue and Forecast, by App (2021-2034)

13.5.8.5. Market Revenue and Forecast, by End-Use (2021-2034)

Chapter 14. Company Profiles

14.1. Bayer AG

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Medtronic

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Roche Diagnostics

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Dexcom Inc. LifeScan Inc.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. AgaMatrix

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. One Drop

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Abbott Laboratories

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Ascensia Diabetes Care

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. ARKRAY Inc

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. ACON Laboratories

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

We use cookies to improve your experience

Digital Diabetes Management Market Size, Report by 2034

List of Contents